Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

SOPHiA GENETICS (SOPH) Net Margin (2020 - 2025)

Historic Net Margin for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to 102.87%.

  • SOPHiA GENETICS's Net Margin rose 134300.0% to 102.87% in Q3 2025 from the same period last year, while for Sep 2025 it was 41.13%, marking a year-over-year increase of 224600.0%. This contributed to the annual value of 95.89% for FY2024, which is 307400.0% up from last year.
  • SOPHiA GENETICS's Net Margin amounted to 102.87% in Q3 2025, which was up 134300.0% from 122.33% recorded in Q2 2025.
  • In the past 5 years, SOPHiA GENETICS's Net Margin ranged from a high of 211.55% in Q2 2022 and a low of 234.67% during Q1 2022
  • In the last 5 years, SOPHiA GENETICS's Net Margin had a median value of 104.39% in 2022 and averaged 81.35%.
  • In the last 5 years, SOPHiA GENETICS's Net Margin plummeted by 2000000000bps in 2021 and then surged by 3922300bps in 2022.
  • Quarter analysis of 5 years shows SOPHiA GENETICS's Net Margin stood at 195.43% in 2021, then skyrocketed by 47bps to 104.39% in 2022, then crashed by -35bps to 141.13% in 2023, then skyrocketed by 39bps to 85.48% in 2024, then dropped by -20bps to 102.87% in 2025.
  • Its Net Margin was 102.87% in Q3 2025, compared to 122.33% in Q2 2025 and 97.78% in Q1 2025.